Edition:
India

Radius Health Inc (RDUS.OQ)

RDUS.OQ on NASDAQ Stock Exchange Global Market

28.32USD
17 Nov 2017
Change (% chg)

$0.28 (+1.00%)
Prev Close
$28.04
Open
$27.82
Day's High
$28.50
Day's Low
$27.82
Volume
200,359
Avg. Vol
338,208
52-wk High
$55.30
52-wk Low
$24.68

Latest Key Developments (Source: Significant Developments)

Radius Health reports Q3 loss per share $1.31
Friday, 3 Nov 2017 

Nov 2 (Reuters) - Radius Health Inc :Radius Health Inc reports third quarter 2017 financial and operating results and provides business update.Q3 loss per share $1.31.Q3 earnings per share view $-1.26 -- Thomson Reuters I/B/E/S.Radius Health Inc - ‍expects to submit a labeling supplement to FDA in connection with activextend results by end of 2017​.Radius health inc - ‍expects to reduce size of board from 10 to 9 members​.Radius Health Inc - believe have sufficient capital to fund development plans, U.S. Commercial and other operational activities for not less than 12 months​.  Full Article

Radius Health receives FDA fast track designation for elacestrant
Wednesday, 18 Oct 2017 

Oct 18 (Reuters) - Radius Health Inc :Radius health receives fda fast track designation for elacestrant (rad1901).Radius health - ‍plans to initiate phase 2 clinical study of elacestrant as a third-line therapy for women with er+ and her2- breast cancer early in 2018​.Radius health inc - ‍expect to enroll first patient in phase 2 study in early 2018​.  Full Article

Radius Health Q2 loss per share $1.01
Thursday, 4 Aug 2016 

Radius Health Inc : Q2 loss per share $1.01 .Q2 earnings per share view $-0.95 -- Thomson Reuters I/B/E/S.  Full Article

Radius Health Inc announces clinical collaboration with Novartis Pharmaceuticals to evaluate RAD1901 combination regimens
Thursday, 28 Jan 2016 

Radius Health Inc:Entered into a worldwide clinical collaboration with Novartis Pharmaceuticals to evaluate the safety and efficacy of combining investigational agent RAD1901.Says parties also intend to conduct pre-clinical studies to evaluate effects of RAD1901 in combination with BYL719.  Full Article

BRIEF-Radius Health reports Q3 loss per share $1.31

* Radius Health Inc reports third quarter 2017 financial and operating results and provides business update